No Data
No Data
No Data
No Data
No Data
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Not Doing Enough For Some Investors As Its Shares Slump 26%
Voyager Therapeutics, Inc. (NASDAQ:VYGR) shares have had a horrible month, losing 26% after a relatively good period beforehand. Longer-term shareholders will rue the drop in the share price, since
Simply Wall St31minutes ago
Express News | Voyager Therapeutics To Present Translational Data For IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials At ASGCT 27th Annual Meeting
Moomoo 24/7Apr 22 16:31 ET
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
- Spotlight on new, second-generation, TRACER-derived AAV capsids; translatability as evidenced by cross-species and receptor data; and activity against therapeutic targets in Alzheimer's disease and
Voyager TherapeuticsApr 22 00:00 ET
Optimistic Buy Rating for Voyager Therapeutics Amid Strong Pipeline and Strategic Partnerships
TipRanksApr 17 05:07 ET
Express News | Selection Of The Development Candidate Triggered A $3M Milestone Payment To Voyager, Which The Company Expects To Receive In Q2 Of 2024
Moomoo 24/7Apr 16 07:12 ET
Express News | Voyager Therapeutics And Neurocrine Biosciences Expect To File An FDA Investigational New Drug Application For GBA1 Program Candidate In 2025
Moomoo 24/7Apr 16 07:07 ET
No Data
No Data